Various vendor strategies in the global allogeneic stem cells market

The global allogeneic stem cells market is expected to grow at a CAGR of 12.32% during the forecast period. Some of the prominent vendors in the global allogeneic stem cells market include Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.

Vendors are focusing on various strategies such as M&A and partnerships to expand their reach in the market. For instance, Cynata Therapeutics Ltd., in September 2019, the company signed a license agreement with FUJIFILM. Under this agreement, FUJIFILM has acquired the right to monopolize the development and sales of Cymerus. Osiris Therapeutics Inc., in April 2019, Smith & Nephew Plc acquired the company, and the latter operates as a wholly owned subsidiary of the former.

Request for: Free Sample Report

Takeda Pharmaceutical Co. Ltd., in January 2019, the company announced the completion of its acquisition of Shire Plc. In January 2019, the company announced a research collaboration with Noile-Immune Biotech Inc., which originated in September 2017. Hence, the rising number of M&A and partnerships is expected to boost the growth of the global allogeneic stem cells market during the forecast period.